May Homira Rezai

MirZyme Therapeutics is an innovative biopharmaceutical company focused on the development and commercialisation of tailored therapeutics to prevent preeclampsia and fetal growth restriction in pregnancy. MirZyme provides a stratified approach to identify patients who will develop preeclampsia and has developed first in class drugs to preventpreeclampsia and fetal growth restrictions. We have two therapeutic approaches, small molecules in capsules form and injectable synthetic miRNAs. MirZyme. One Test. One Pill. Save Two Lives.